Bettina Wedi

12.3k total citations · 1 hit paper
157 papers, 3.8k citations indexed

About

Bettina Wedi is a scholar working on Rheumatology, Dermatology and Immunology and Allergy. According to data from OpenAlex, Bettina Wedi has authored 157 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Rheumatology, 61 papers in Dermatology and 58 papers in Immunology and Allergy. Recurrent topics in Bettina Wedi's work include Urticaria and Related Conditions (84 papers), Autoimmune Bullous Skin Diseases (42 papers) and Allergic Rhinitis and Sensitization (38 papers). Bettina Wedi is often cited by papers focused on Urticaria and Related Conditions (84 papers), Autoimmune Bullous Skin Diseases (42 papers) and Allergic Rhinitis and Sensitization (38 papers). Bettina Wedi collaborates with scholars based in Germany, Austria and United States. Bettina Wedi's co-authors include Alexander Kapp, Ulrike Raap, Marcus Maurer, Hans F. Merk, Torsten Zuberbier, Giorgio Walter Canonica, Carsten Bindslev‐Jensen, Clive Grattan, D. Wieczorek and Petra Staubach and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gut.

In The Last Decade

Bettina Wedi

134 papers receiving 3.6k citations

Hit Papers

EAACI/GA2LEN/EDF/WAO guid... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bettina Wedi Germany 28 2.4k 1.3k 1.2k 1.1k 1.1k 157 3.8k
Karsten Weller Germany 37 3.7k 1.5× 851 0.7× 2.0k 1.7× 1.4k 1.3× 2.2k 2.1× 143 5.3k
Alicja Kasperska−Zając Poland 24 935 0.4× 254 0.2× 439 0.4× 427 0.4× 379 0.4× 99 1.7k
Paul C. Atkins United States 28 508 0.2× 817 0.6× 164 0.1× 385 0.3× 299 0.3× 96 2.4k
Joseph Tauber United States 28 427 0.2× 741 0.6× 340 0.3× 672 0.6× 202 0.2× 65 3.8k
Antonio Valero Spain 31 426 0.2× 1.5k 1.2× 149 0.1× 520 0.5× 160 0.2× 113 2.6k
Vito Sabato Belgium 33 516 0.2× 2.1k 1.7× 71 0.1× 889 0.8× 97 0.1× 174 3.3k
Barbara Frossi Italy 26 366 0.1× 463 0.4× 164 0.1× 182 0.2× 188 0.2× 48 2.3k
Hideshi Torii Japan 30 408 0.2× 579 0.5× 293 0.2× 1.4k 1.3× 31 0.0× 65 3.2k
Laurent L. Reber France 28 442 0.2× 1.1k 0.8× 43 0.0× 288 0.3× 112 0.1× 55 2.9k
Hsin‐Hui Yu Taiwan 25 435 0.2× 270 0.2× 102 0.1× 290 0.3× 82 0.1× 72 2.0k

Countries citing papers authored by Bettina Wedi

Since Specialization
Citations

This map shows the geographic impact of Bettina Wedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Wedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Wedi more than expected).

Fields of papers citing papers by Bettina Wedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Wedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Wedi. The network helps show where Bettina Wedi may publish in the future.

Co-authorship network of co-authors of Bettina Wedi

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Wedi. A scholar is included among the top collaborators of Bettina Wedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Wedi. Bettina Wedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gehring, Manuela, et al.. (2025). Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes. European Journal of Immunology. 55(7). e70010–e70010.
2.
Wedi, Bettina. (2025). Biologic and small molecule therapies in chronic spontaneous urticaria: an update. Current Opinion in Allergy and Clinical Immunology. 25(5). 418–425.
3.
Zuberbier, Torsten, Sabine Altrichter, Randolf Brehler, et al.. (2023). S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(1). 81–93. 2 indexed citations
4.
Zuberbier, Torsten, Sabine Altrichter, Randolf Brehler, et al.. (2023). S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(2). 202–215. 3 indexed citations
5.
Kocatürk, Emek, Melba Muñoz, Daniel Elieh Ali Komi, et al.. (2023). How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19. Viruses. 15(7). 1585–1585. 13 indexed citations
6.
Zuberbier, Torsten, Sabine Altrichter, Randolf Brehler, et al.. (2023). S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(2). 202–216. 4 indexed citations
7.
Worm, Margitta, Andrea Bauer, Regina Treudler, et al.. (2022). Management of suspected and confirmedCOVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity. Allergy. 77(11). 3426–3434. 11 indexed citations
9.
Weller, Karsten, Marcus Maurer, Andrea Bauer, et al.. (2021). Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. Journal of the European Academy of Dermatology and Venereology. 36(1). 91–99. 35 indexed citations
10.
Traidl, Stephan, et al.. (2020). Langerhans cell histiocytosis mimicking prurigo nodularis. Journal of the European Academy of Dermatology and Venereology. 35(4). e259–e261. 1 indexed citations
11.
Magerl, Markus, M. Rother, Thomas Bieber, et al.. (2012). Randomized, double‐blind, placebo‐controlled study of safety and efficacy of miltefosine in antihistamine‐resistant chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 27(3). e363–9. 22 indexed citations
12.
Wedi, Bettina. (2008). Stellenwert und Indikation der SLIT im Vergleich zur SCIT. Der Hautarzt. 59(7). 537–543. 2 indexed citations
13.
Bachert, Claus, Karl‐Christian Bergmann, T Bieber, et al.. (2007). Present role of sublingual immunotherapy in allergic diseases. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
14.
Bachert, Claus, Bettina Wedi, Ludger Klimek, et al.. (2006). Allergische Rhinokonjunktivitis
Leitlinie der DGAI in Abstimmung mit der DDG. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 4(3). 264–275. 11 indexed citations
15.
Wedi, Bettina & Alexander Kapp. (2006). Aktuelle Positionsbestimmung zur Bedeutung von Nahrungsmittelallergien und -unverträglichkeiten bei der Urtikaria. Der Hautarzt. 57(2). 101–107. 5 indexed citations
16.
Wedi, Bettina, T. Fuchs, Jörg Kleine‐Tebbe, Ralph Mösges, & Johannes Ring. (2004). Ebastine - review of the efficacy and safety profile of a nonsedating antihistamine. mediaTUM (Technical University of Munich). 1 indexed citations
17.
Bachert, Claus, U. Borchard, Bettina Wedi, et al.. (2003). Guidelines of the DGAI on allergic rhinoconjunctivitis. Allergologie. 26(4). 147–162. 7 indexed citations
18.
Bischoff, Stephan C., Julika Mayer, Jochen Wedemeyer, et al.. (1997). Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy.. Gut. 40(6). 745–753. 112 indexed citations
19.
Czech, Wolfgang, Antonia Busse, Bettina Wedi, & Alexander Kapp. (1996). Nahrungsmitteladditiva und nicht steroidale Antiphlogistika- Auslöser von pseudoallergischen Reaktionen. FreiDok plus (Universitätsbibliothek Freiburg). 2 indexed citations
20.
Wedi, Bettina, Jörn Elsner, & Alexander Kapp. (1994). Differential expression of ICAM-1 in the human mast cell line HMC-1. Journal of Investigative Dermatology. 103(4). 621. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026